Research output per year
Research output per year
Personal profile
Expertises
Expertise and knowledge of pathology, molecular techniques, translational research in biomarkers and biobanking.
Head of Nationwide: "Regionernes Bio- and GenomBank (RBGB)
"Main research areas
My main research area is in biomarkers of colorectal, breast and gynecologic tumors. In addition, I also focus on stability and heterogeneity studies as several markers have been proven to require special considerations before an analysis can be performed with conclusive result to follow.
Current research
My current research focus on:
- Genomic alterations in colorectal -, breast and ovarian cancer using Next Generation Sequencing (NGS)
- miRNA (miR) profiles as predictive and prognostic biomarkers in colorectal and ovarian cancer
- Genomic alterations as basis for experimental precision medicine
- How to optimize infra-structure for biomedical research
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Estrid Vilma Solyom Høgdall is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
A Review of Major Danish Biobanks: Advantages and Possibilities of Health Research in Denmark
Laugesen, K., Mengel-From, J., Christensen, K., Olsen, J., Hougaard, D. M., Boding, L., Olsen, A., Erikstrup, C., Hetland, M. L., Høgdall, E., Kjaergaard, A. D., Sørensen, E., Brügmann, A., Petersen, E. R. B., Brandslund, I., Nordestgaard, B. G., Jensen, G. B., Skajaa, N., Troelsen, F. S., Fuglsang, C. H., & 2 others, 2023, In: Clinical Epidemiology. 15, p. 213-239 27 p.Research output: Contribution to journal › Review › peer-review
-
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
Kang, E-Y., Weir, A., Meagher, N. S., Farrington, K., Nelson, G. S., Ghatage, P., Lee, C-H., Riggan, M. J., Bolithon, A., Popovic, G., Leung, B., Tang, K., Lambie, N., Millstein, J., Alsop, J., Anglesio, M. S., Ataseven, B., Barlow, E., Beckmann, M. W., Berger, J., & 31 others, 1 Mar 2023, In: Cancer. 129, 5, p. 697-713 17 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)
Chen, I. M., Donia, M., Chamberlain, C. A., Jensen, A. W. P., Draghi, A., Theile, S., Madsen, K., Hasselby, J. P., Toxværd, A., Høgdall, E., Lorentzen, T., Wilken, E. E., Geertsen, P., Svane, I. M., Johansen, J. S. & Nielsen, D., 2023, In: European journal of cancer (Oxford, England : 1990). 180, p. 125-133 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol
Spindler, N. J., Persson, G. F., Theile, S., Nielsen, D. L., Høgdall, E. V., Al-Farra, G., Hendel, H. W., Lorentzen, T., Svane, I. M., Lindberg, H. & Eefsen, R. L., 30 Jan 2023, In: BMJ Open. 13, 1, p. e063500 e063500.Research output: Contribution to journal › Journal article › Research › peer-review
-
Therapy with pembrolizumab in treatment-naive patients with nonmetastatic, mismatch repair deficient colorectal cancer
Eefsen, R. L., Larsen, J. S., Klarskov, L. L., Altaf, R., Høgdall, E., Ingeholm, P., Lykke, J., Nielsen, D. L., Pfeiffer, P., Poulsen, L. Ø., Qvortrup, C., Schou, J. V., Mau-Sørensen, M., Østerlind, K. & Jensen, B. V., 15 May 2023, In: International Journal of Cancer. 152, 10, p. 2145-2152 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
Activities
- 1 Other (prizes, external teaching and other activities) - Other
-
Phd.-vejleder for Farah Diba Begum
Estrid Vilma Solyom Høgdall (Participant)
2007 → 2010Activity: Other › Other (prizes, external teaching and other activities) - Other